Metaplastic esophageal columnar epithelium without goblet cells shows DNA content abnormalities similar to goblet cell-containing epithelium

American Journal of Gastroenterology

Volumn 104, Issue 4, 2009, Pages 816-824

  Liu, Weitian ^a,b   Hahn, Hejin ^a   Odze, Robert D ^a   Goyal, Raj K ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

ANEUPLOIDY; ARTICLE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL DENSITY; COLUMNAR EPITHELIUM; CONTROLLED STUDY; DNA CONTENT; ESOPHAGUS BIOPSY; ESOPHAGUS METAPLASIA; ESOPHAGUS MUCOSA; GOBLET CELL; HISTOGRAM; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMAGE CYTOMETRY; METAPLASIA; PRIORITY JOURNAL; STOMACH MUCOSA; BARRETT ESOPHAGUS; BIOPSY; CELL COUNT; CHEMISTRY; COMPARATIVE STUDY; EPITHELIUM; ESOPHAGUS; FLOW CYTOMETRY; GENETICS; INTESTINE MUCOSA; PATHOLOGY; PRECANCER; RETROSPECTIVE STUDY;

ANEUPLOIDY; BARRETT ESOPHAGUS; BIOPSY; CELL COUNT; DNA, NEOPLASM; EPITHELIUM; ESOPHAGUS; FLOW CYTOMETRY; GOBLET CELLS; HUMANS; INTESTINAL MUCOSA; METAPLASIA; PRECANCEROUS CONDITIONS; RETROSPECTIVE STUDIES;

EID: 65449135220     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2009.85     Document Type: Article

References (35)

1. Hornick JL, Odze RD. Neoplastic precursor lesions in Barrett's esophagus. Gastroenterol Clin North Am 2007;36:775-96.
2. Yousef F, Cardwell C, Cantwell MM et al. The incidence of esophageal. cancer and high-grade dysplasia in Barreft's esophagus: a systemafic review and meta-analysis. Am I Epidemiol 2008;168:237-49.
3. Wang KK, Sampliner RE. Practice Parameters Commfttee of the American College of Gastroenterology. Updated guidelines 2008 for the diagnosis, surveillance and therapy of Barrett s esophagus. Am J Gastroenterol 2008; 103:788-97.
4. Sharma P, McQuaid K, Dent I et al. A critical. review of the diagnosis and management of Barreffs esophagus: the AGA Chicago workshop. Gastroenterology 2004:127:310-30.
5. Playford RI. New British Society of Gastroenterology (BSG) guidelines for the diagnosis and management of Barrett's oesophagus. Gut 2006;55:442.
6. Paull A, Trier IS, Dakon MD et al. The hismlogic spectrum of Barrett's esophagus. N Engi J Med 1976;295:476-80.
7. IViurray L, Watson P, Johnston B et al. Risk of adenocarcinoma in Barrett's oesophagus: population based study. BMJ 2003;327:534-5.
8. KerkhofM, Bax DA, Moons LM et al. For The Cybar Study Group. Does CDX2 expression predict Barrett's metaplasia in oesophageal. columnar epithelium without goblet cells? Aliment Pharmacol Ther 2006;24: 16 13-2 1.
9. Chaves P, Crespo M, Ribeiro C et al. Chromosomal. analysis of Barrett's cells: demonstration of instability and detection of the metaplastic lineage involved. Mod Pathol 2007;20:788-96.
10. Kelly CJ, Gough MD, Van Wyk Q et al. Barrett's oesophagus: intestinal. metaplasia is not essential. for cancer risk. Scand J Gastroenterol 2007;42: t27t-4.
11. Gatenby PA, Ramus JR, Caygill CP et al. Relevance of the detection of intestinal. metaplasia in non-dysplastic columnar-Ithed oesophagus. Scand Gastroenterol 2008;43:524-30.
12. Reid BJ, Blount PL, Rabinovitch PS. Biomarkers in Barrett's esophagus. Gastrointest Endosc din N Am 2003;13:369-97.
13. Rajagopalan H, Jallepalli PV, Rago C et al. Inactivation ofhCDC4 can cause chromosomal. instability. Nature 2004;428:77-8 1.
14. Ducsberg P, Li R, Rasnick D. Ancuploidy approaching a perfect score in predicting and preventing cancer: highlights from a conference held in Oakland, CA in January, 2004. Cell Cycle 2004;3:823-8.
15. Fang M, Lew E, Klein M et al. DNA abnormalities as marker of risk for progression of Barrett's esophagus to adenocarcinoma: image cytomctric DNA analysis in formalin-fixed tissues. Am J Gastroenterol 2004;99: 1887-94.
16. Yu C, Zhang X, Huang Q et al. High-fidelity DNA histograms in neoplastic progression in Barrett's esophagus. Lab Invest 2007;87:466-72.
17. Steinbeck RG. Dysplasia in view of the cell cycle. Lur J Histochem 2004;48:203-t t.
18. Huang Q, Yu C, Zhang X et al. Comparison of DNA histograms by standard flow cytometry and image cytometry on sections in Barrett's adenocarcinoma. BMC Clin Pathol 2008;8:5.
19. Zhang X, Huang Q, Goyal. RK et al. DNA ploidy abnormalities in basal. and superficial. regions of the crypts th barrett's esophagus and associated neoplastic lesions. Am J Surg Pathol 2008;32:1327-35.
20. Hornick JL, Mino-Kcnudson lvi, Lauwers GY et al. Buried Barrett's epithelium followthg photodynamic therapy shows reduced crypt proliferation and absence of DNA content abnormalities. Am J Gastroenterol 2008;103:38-47.
21. Takubo K, Aida 1. Namoto Y et al. Cardiac rather than intestinal-type background in endoscopic resection specimens of minute Barrett adenocarcinoma. Hum Pathol 2009;40:65-74.
22. Chandrasoma PT, Der R, Ma Y et al. Histology of the gastro-esophageal. junction-an autopsy stud). Am J Surg Pathol 2000;24:402-9.
23. Trier JS. Morphology of the epithelium of the distal. esophagus in patients with mid esophageal. peptic strictures. Gastroenterology 1970;58:444-61.
24. Huang Q, Yu C, Klein lvi et al. DNA index determination with Automated Cellular Imaging System (ACIS) in Barrett's esophagus: comparison with CAS 200. BMC Chn Pathol 2005;5:7.
25. Walch AK, Zitzelsberger HF, Bruch J et al. Chromosomal. imbalances in Barrett's adenocarcinoma and the metaplasia-dysplasia-carcinoma sequence. Am J Pathol 2000;156:555-66.
26. Lorenzato lvi, Abboud P, Masure M et al. Image cytometry detection of breast cancer cells with 5C DNA content and minor DNA stemlines. Anal. Quant Cytol Histol 2000;22:199-205.
27. Kroncnwett U, Huwendiek 5, Ostring C et al. Improved grading of breast adenocarcinomas based on genomic instability Cancer Res 2004;64:904-9.
28. Reid BJ, Prevo Lb Gallpeau PC et al. Predictors of progression in Barrett's esophagus II: baseline I7p (p53) loss of heterozygosity identifies a patient subset al. increased risk for neoplastic pmgression. Am J Gastroenterol 200 1;96:2839-48.
29. Wong DJ, Paulson TG, Prevo U et al. P16(INK4a) lesions are common, early abnormalities thal. undergo clonal. expansion in Barrett's metaplastic epithelium. Cancer Res 200 1;61 :8284-9.
30. Koppert LB, Wijnhox en BR van Dekken H et al. The molecular biology of esophageal. adenocarcinoma. I Surg Oncol 2005;92:169-90; review.
31. Romagnoh 5, Roncalli M, Graziani D et al. Molecular alterations of Barretfs esophagus on microdissected endoscopic biopsies. Lab Invest 2001;81:241-7.
32. Lord 1W Wickramasinghe K, Johansson JJ et al. Cardiac mucosa in the remnant esophagus after esophagectomy is an acquired epithelium with Barrett's-like features. Surgery 2004; 136:633-40.
33. Glickman JN, Wang H, Das KIvI et al. Phenotype of Barrett's esophagus and intestinal. metaplasia of the distal. esophagus and gastroesophageal. junction: an immunohistochemical. study of cytokeratins 7 and 20, Das-1 and 45 MI. Am I Surg Pathol 200 1;25:87-94.
34. Spechler SJ, Goyal. RK. The columnar-lined esophagus, intestinal. metaplasia, and Norman Barrett. Gastrocnterology 1996;110:614-21.
35. Rubenstein JH, Saini SD, Kuhn L et al. Influence of malpractice history on the practice of screening and surveillance for Barrett's esophagus. Am Gastroentcrol 2008;103:842-9.